Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|December 26, 2022
Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot studyJeanine H C Arkenbosch, Oddeke van Ruler, Roy S Dwarkasing, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 24, 2020
Bridging-to-Surgery in Patients with Type 2 Intestinal FailureFleur E E de Vries, Jeroen J M Claessen, Elina M S van Hasselt-Gooijer, et al.World Journal of Gastroenterology|August 18, 2022
Prehabilitation prior to intestinal resection in Crohn's disease patients: An opinion reviewMichiel T J Bak, Marit F E Ruiterkamp, Oddeke van Ruler, et al.Inflammatory Bowel Diseases|May 24, 2025
Intraoperative Autologous Platelet-Rich Stroma Injection as Add-On to Fistula Curettage and Closure of the Internal Orifice Demonstrates a Favorable Outcome in Long-Term in Patients Suffering from Therapy-Refractory Perianal Fistulizing Crohn's DiseaseMichiel T J Bak, Annemarie C de Vries, Caroline D M Witjes, et al.Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.Journal of Crohn'S & Colitis|September 12, 2018
Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's DiseaseE Joline de Groof, Jonathan H M van der Meer, Pieter J Tanis, et al.Bioengineering (Basel, Switzerland)|February 26, 2025
Additional Intraoperative Autologous-Derived Platelet-Rich Stroma to Transanal Flap Repair for the Treatment of Cryptoglandular Transsphincteric Fistulas in a Tertiary Referral Center: Long-Term Outcomes of a Prospective Pilot StudyMichiel T J Bak, Caroline D M Witjes, Roy S Dwarkasing, et al.Health and Quality of Life Outcomes|July 3, 2007
Health related quality of life six months following surgical treatment for secondary peritonitis--using the EQ-5D questionnaireKimberly R Boer, Oddeke van Ruler, Johannes B Reitsma, et al.Critical Care (London, England)|May 29, 2010
Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trialBrent C Opmeer, Kimberly R Boer, Oddeke van Ruler, et al.European Journal of Gastroenterology & Hepatology|December 5, 2022
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapySebastiaan Ten Bokkel Huinink, Evelien M J Beelen, Thomas Ten Bokkel Huinink, et al.Pageof 4